Drugs News and Research

RSS

Multiple sclerosis may be caused by infection with the Epstein-Barr virus

Multiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure, is likely caused by infection with the Epstein-Barr virus (EBV), according to a study led by Harvard T.H. Chan School of Public Health researchers.

13 Jan 2022

Researchers identify gene variant that protects against severe COVID-19

An international metastudy led by researchers at Karolinska Institutet in Sweden has identified a specific gene variant that protects against severe COVID-19 infection.

13 Jan 2022

KHN’s ‘What the Health?’: Dealing with drug prices

Medicare officials have preliminarily decided to restrict reimbursement for Aduhelm, the controversial Alzheimer's drug, to only patients participating in approved clinical trials.

13 Jan 2022

Macrophages in the arteries can "sniff" out their surroundings and cause inflammation

An artery is not like a nose. Or is it? Scientists at La Jolla Institute for Immunology (LJI) have discovered that immune cells in arteries can "sniff" out their surroundings and cause inflammation.

13 Jan 2022

New combination immune therapy for cancer is effective and has fewer side effects, study finds

Google "chemotherapy side effects" and the results abound. Nausea, anemia, infection, fertility problems, kidney problems, mouth sores. The list goes on and on.

13 Jan 2022

Defective gene in blood cancers could be treated with already available drugs

A defective gene, normally found in blood cancers, could be treated with drugs already available for cancers with similar gene defects, scientists at Queen’s University Belfast and the University of Birmingham have revealed.

13 Jan 2022

Novel biomarker can be used to identify disease progression in ALS

An international collaboration led by Flinders University has identified a potential biomarker for amyotrophic lateral sclerosis, also known as Motor Neuron Disease, providing a way to test the effectiveness of future clinical trials.

13 Jan 2022

Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix

Malvern Panalytical, a company providing advanced analysis and services solutions for the pharma drug product development, as well as services and solutions for other industries, has today announced its acquisition of Creoptix AG, a specialist bioanalysis sensor company.

From Malvern Panalytical 13 Jan 2022

$Common osteoporosis medications protect against hip fracture during a 2-year drug holiday$

Common osteoporosis medications protect against hip fracture during a 2-year drug holiday

New research findings may help physicians and older adults with osteoporosis better manage their hip fracture risk while taking a break from their medication. The first-of-its-kind study, published in the Annals of Internal Medicine, found that the oral bisphosphonates risedronate and alendronate equally protect against hip fracture during a 2-year drug holiday.

13 Jan 2022

Cannabinoids may prevent infection with SARS-CoV-2, including variants

A new study published in the Journal of Natural Products of the American Chemical Society and American Society of Pharmacognosy has shown that isolated cannabinoids or those in hemp extracts have the potential to prevent and treat the infection with the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) – primarily by blocking viral cell entry.

13 Jan 2022

Specification of fictitious added benefit upon market access of orphan drugs not confirmed

In order to promote the development of drugs for rare diseases (orphan drugs) despite market risks, in Germany they are exempt from the regular benefit assessment procedure introduced in 2011 with the Act on the Reform of the Market for Medicinal Products (AMNOG).

13 Jan 2022

Study finds evidence for increased activity of the brain’s immune system long before dementia onset

Long before the onset of dementia, there is evidence for increased activity of the brain's immune system. Researchers from DZNE and the University Hospital Bonn come to this conclusion based on a study of more than 1,000 older adults.

12 Jan 2022

Living alone, serial break-ups may raise the levels of inflammatory markers in men

Living alone for several years and/or experiencing serial relationship break-ups are strongly linked to raised levels of inflammatory markers in the blood-but only in men-finds a large population study published online in the Journal of Epidemiology & Community Health.

12 Jan 2022

The impact of Comirnaty vaccination on the levels of PEG specific antibodies

Researchers observe an increase in PEG antibodies following vaccination with the SARS-CoV-2 mRNA lipid nanoparticle vaccine.

12 Jan 2022

Metabolic vulnerabilities in malignant cells may lead to new breast cancer therapies

Metabolic differences could explain why some metastatic breast cancer cells rapidly generate tumors after migrating from primary tumors to the brain, while others linger for months or years before forming these secondary tumors, UT Southwestern scientists report in a new study.

12 Jan 2022

Newly designed biochip simplifies the process of manufacturing in vitro skin in the laboratory

Researchers from the Universidad Carlos III de Madrid, the Universidad Politécnica de Madrid (UPM) and other entities have designed a new biochip, a device that simplifies the process of manufacturing in vitro skin in the laboratory and other complex multi-layer tissues.

12 Jan 2022

Novel insights about dopamine can help find better drugs for Parkinson's patients

New findings provide a better understanding of how the synthesis of dopamine is regulated in the brain. It may shed new light on the mechanism behind diseases such as Parkinson's.

12 Jan 2022

Long-term use of blood pressure medication could be contributing to kidney damage

New kidney research from the University of Virginia School of Medicine is raising concerns that long-term use of drugs commonly prescribed to treat high-blood pressure and heart failure could be contributing to kidney damage.

12 Jan 2022

UCLA-led researchers improve method that was designed to kill HIV-infected cells

In a study using mice, a UCLA-led team of researchers have improved upon a method they developed in 2017 that was designed to kill HIV-infected cells.

12 Jan 2022

UCLA study provides new insights into molecular 'crosstalk' in pancreas cancer cells

Research led by scientists at the Jonsson Comprehensive Cancer Center (JCCC) at UCLA provides new insights into molecular "crosstalk" in pancreas cancer cells, identifying vulnerabilities that could provide a target for therapeutic drugs already being studied in several cancers.

12 Jan 2022

Drugs News and Research

Multiple sclerosis may be caused by infection with the Epstein-Barr virus

Researchers identify gene variant that protects against severe COVID-19

KHN’s ‘What the Health?’: Dealing with drug prices

Macrophages in the arteries can "sniff" out their surroundings and cause inflammation

New combination immune therapy for cancer is effective and has fewer side effects, study finds

Defective gene in blood cancers could be treated with already available drugs

Novel biomarker can be used to identify disease progression in ALS

Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix

Common osteoporosis medications protect against hip fracture during a 2-year drug holiday

Cannabinoids may prevent infection with SARS-CoV-2, including variants

Specification of fictitious added benefit upon market access of orphan drugs not confirmed

Study finds evidence for increased activity of the brain’s immune system long before dementia onset

Living alone, serial break-ups may raise the levels of inflammatory markers in men

The impact of Comirnaty vaccination on the levels of PEG specific antibodies

Metabolic vulnerabilities in malignant cells may lead to new breast cancer therapies

Newly designed biochip simplifies the process of manufacturing in vitro skin in the laboratory

Novel insights about dopamine can help find better drugs for Parkinson's patients

Long-term use of blood pressure medication could be contributing to kidney damage

UCLA-led researchers improve method that was designed to kill HIV-infected cells

UCLA study provides new insights into molecular 'crosstalk' in pancreas cancer cells

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News